Medical ethicists to meet on use of experimental Ebola drugs
Medical ethicists will meet next week to discuss the use of experimental medicines in the West African Ebola outbreak. The World Health Organization (WHO) announced the talks in the wake of a controversial decision to treat two infected American aid workers with ZMapp, an Ebola serum never before tested on humans. The move sparked debate over whether using experimental Ebola treatments is ethical and why Africans have not been offered the same option.
We are in an unusual situation in this outbreak. We have a disease with a high fatality rate without any proven treatment or vaccine, Marie-Paule Kieny, assistant director-general at the WHO, said in a Thursday statement announcing the meeting. We need to ask the medical ethicists to give us guidance on what the responsible thing to do is.
Meanwhile, Tekmira Pharmaceuticals, based in Vancouver, Canada, announced Thursday that the U.S. Food and Drug Administration has amended the trials of Tekmiras drug TKM-Ebola to partial hold status which the company said in a news release enables potential treatment with the drug for those already infected.
This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols, Tekmira CEO and president Mark Murray said in a statement issued on Thursday .
O n Wednesday three of the United Kingdoms leading Ebola specialists including the Peter Piot, who discovered the deadly virus in 1976 called in a joint statement for Africans governments to be allowed to make informed decisions about whether or not to use these products.The Americans are still alive and appear to be recovering which is significant, since the mortality rate of the current outbreak is about 60 percentSome experts have pointed out that because of past controversial drug testing by Western companies on Africansthe perception of the U.S. government or private companies first offering experimental drugs to African governments could have been very negative.
It would have been the front-page screaming headline Africans used as guinea pigs for American drug companys medicine, Salim S. Abdool Karim, director of Caprisa, an AIDS research center in South Africa, said in an interview with The New York Times .
http://america.aljazeera.com/articles/2014/8/8/ebola-ethics-drugs.html

I'm glad they're moving forward on compassionate use.
Whatever they are going to do they need to get the ball rolling. People are dying.
If they wanted to test the drug on someone without appearing to be using Africans as guinea pigs, surely there were/are still some aid workers in the areas who can be considered as educated and informed enough to volunteer as test subjects.
Just read on Yahoo News that in Liberia police are having to try and control riots. In spite of being told not to do it, people are throwing the bodies of their deceased into the streets for the police to come and pick up, just to get them out of the house. It is a dreadful situation, and I just can't even imagine being their place.
It may have come out as harsh, Rescue, but if they live in the area and aren't leaving and their chances of coming down with it are great, they might want to. That's all I'm saying.
If I lived there and saw my family and friends dying around me with no end in sight, yes, I would volunteer. I would much rather volunteer and take my chances; either I would die and not have to witness another loved one going through this horrible disease, or I would not, and would be thankful I had a part in saving the lives of those I love.
I would look at it as a win, either way.
Now, if I had the option to run away to another country, to possibly escape it, I would probably do that, too, provided my family were not in the country I was running from.
I read a news article two days ago that said Ebola was already in Italy, has been since March and there is a media blackout on it.
The little island of Lampadeusia where thousands of illegal refugees come ashore claiming to have relatives in both France and Italy is said to be quarantined due to African illegals bringing it ashore.
Maybe the reason the US is balking on giving Africa the drug is simply because they don't have enough of it right now... that they are already giving what they have to some other location we don't know about.
Thank you for noticing, Mike.
This is correct. When a drug or vaccine is in development, batches are produced in enough numbers to conduct the clinical trials. These numbers are decided very early on, while the clinical protocol is still being developed and based on the calculated sample sizes of the trials.
This is why there isn't enough of it right now
actually, it is the other way around. It's a process called "adaptation". The virus is "free"in nature allowing it to replicate in different situations. This is why vaccines are developed.
If the US wants to be able to invest that $14billion in Africa and its resources, I have a feeling we'd best get moving on improving the quantity of that drug. It may very well be included as part of the bargaining before the US is allowed into Africa.
I just don't think, with Ebola running rampart on the continent there, that "It has to go through trials," and "We're not even sure it had anything to do with the improving health of our two doctors" is going to make any difference to African leaders.
Rescue--
This post regarding the WHO request in combination the change in FDA status seems to me to suggest that the medical ethics issues are at least being questioned (and possibly amended in this instance), which is exactly the point that a few of us were raising in your earlier article.
IMO this speaks directly to the issues in debate in your earlier piece--- if the governments of Liberia et al request that their citizens be allowed to volunteer to use the serum, the whole 'Africans used as American guinea pigs' is obviated, no? Whether the individuals in that "uneducated, suspicious, 3rd world country... we can never understand or even fathom their mindset" will accept the treatment is a separate concern. (I'd note that pics in your other article demonstrate that in facta fair number of those undeducated suspicious 3rd world cntizens aren't averse to being treated by "a stranger in a space suit with a needle and syringe".)
To your last response to MiG:
If indeed the solution may bethat simple, there are now two possible avenues of treatment, either of which should be made available to the people living in that situation. We all realize that neither ZMapp nor antibody transfusions in the 'uncontrolled setting' of the Ebola outbreak will constitute the clinical trials that are needed by the FDA, but that isn't the point that some of us are trying to make here.
People watching 60% of their neighbors, friends & family members being swept away in a flood just might not give a damn if the available sandbags are 'government approved'-- doesn't take a cultural anthropologist to fathom that mindset...
It has to go through trials mimi, there's no escaping it